Daesung Microbiological Labs. Co. Ltd (036480) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.027x

Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩972.26 Million ≈ $658.89K USD) by net assets (₩35.42 Billion ≈ $24.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Daesung Microbiological Labs. Co. Ltd worth for the company's overall valuation and market capitalisation.

Daesung Microbiological Labs. Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Daesung Microbiological Labs. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Daesung Microbiological Labs. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daesung Microbiological Labs. Co. Ltd ranked by their cash flow conversion efficiency. Explore 036480 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Orbital Corporation Ltd AU:OEC	0.024x
Indian Terrain Fashions Limited NSE:INDTERRAIN	0.029x
PRI EKOPARK SA ZY -10 F:NPA	0.542x
SYZYGY AG XETRA:SYZ	-0.086x
Good Times Restaurants Inc NASDAQ:GTIM	0.049x
Organic Tea Cosmetics Holdings Company Limited KQ:900300	0.294x
Alma Metals Ltd AU:ALM	0.228x
Hanchang KO:005110	0.818x

Annual Cash Flow Conversion Efficiency for Daesung Microbiological Labs. Co. Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. View Daesung Microbiological Labs. Co. Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩35.42 Billion ≈ $24.00 Million	₩1.41 Billion ≈ $955.61K	0.040x	-33.46%
2024-12-31	₩35.15 Billion ≈ $23.82 Million	₩2.10 Billion ≈ $1.43 Million	0.060x	+281.12%
2023-12-31	₩37.35 Billion ≈ $25.31 Million	₩-1.23 Billion ≈ $-836.14K	-0.033x	-211.04%
2022-12-31	₩38.84 Billion ≈ $26.32 Million	₩1.16 Billion ≈ $783.00K	0.030x	-50.04%
2021-12-31	₩37.00 Billion ≈ $25.08 Million	₩2.20 Billion ≈ $1.49 Million	0.060x	-33.19%
2020-12-31	₩36.31 Billion ≈ $24.61 Million	₩3.24 Billion ≈ $2.19 Million	0.089x	+35.07%
2019-12-31	₩35.09 Billion ≈ $23.78 Million	₩2.32 Billion ≈ $1.57 Million	0.066x	-30.56%
2018-12-31	₩33.01 Billion ≈ $22.37 Million	₩3.14 Billion ≈ $2.13 Million	0.095x	+71.29%
2017-12-31	₩30.30 Billion ≈ $20.53 Million	₩1.68 Billion ≈ $1.14 Million	0.055x	-54.29%
2016-12-31	₩29.01 Billion ≈ $19.66 Million	₩3.52 Billion ≈ $2.39 Million	0.121x	-60.26%
2015-12-31	₩25.09 Billion ≈ $17.01 Million	₩7.66 Billion ≈ $5.19 Million	0.305x	+68.35%
2014-12-31	₩21.14 Billion ≈ $14.32 Million	₩3.83 Billion ≈ $2.60 Million	0.181x	+89.22%
2013-12-31	₩19.72 Billion ≈ $13.36 Million	₩1.89 Billion ≈ $1.28 Million	0.096x	-18.93%
2012-12-31	₩19.73 Billion ≈ $13.37 Million	₩2.33 Billion ≈ $1.58 Million	0.118x	--

About Daesung Microbiological Labs. Co. Ltd

KQ:036480 Korea Biotechnology

Market Cap

$15.84 Million

₩23.37 Billion KRW

Market Cap Rank

#25917 Global

#1940 in Korea

Share Price

₩6150.00

Change (1 day)

+0.16%

52-Week Range

₩5590.00 - ₩9880.00

All Time High

₩27216.09